news
Novel anti-psychotic shows promise in Phase II schizophrenia trial
KarXT significantly reduced both positive and negative of symptoms of schizophrenia without the common problematic side effects of current antipsychotic therapies.
List view / Grid view
Columbia University
news
Study finds some antibody therapies are not effective against new COVID-19 variants
In vitro neutralisation assays show REGEN-COV and AZD7442 are effective against the new SARS-CoV-2 variants, while other antibody therapies, including Eli Lilly’s bamlanivimab, were not.
article
Nanoparticle delivery offers a possible alternative to opioid pain relief
An international team of researchers has used nanoparticles to deliver a drug – one that previously failed in clinical trials for pain – into specific compartments of nerve cells, dramatically increasing its ability to treat pain in mice and rats. Nikki Withers spoke to Nigel Bunnett to hear more about…
news
Nanoparticle drug delivery provides pain relief and opioid alternative
Researchers have used nanoparticles to infuse a non-opioid drug into nerves to provide enhanced pain relief.
news
NIR identifies breast cancer patients who will benefit from chemotherapy
Scientists have developed a new optical imaging system that uses red and near-infrared light to identify breast cancer patients who will respond to chemotherapy...
